Companies
Chenguang Biotech Group
- Country
- China
Coverage
| CN | EU | US | |
|---|---|---|---|
| downstream-purification | ✓ | ✓ | ✓ |
Regulatorsepafdanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Capacity | 1 billion softgels, 1 billion capsules, and 1 billion tablets annually at the Handan facility medium confidence | wlw.com |
| Certification | BRCGS, ISO9001, ISO22000, ISO14001, ISO45001, KOSHER, HALAL, FAMI-QS, SEDEX, cGMP, and intellectual property management system certification | en.cn-cg.com |
| Regulatory approval | FDA product registration | en.cn-cg.com |
| Production site | Over 30 subsidiaries (branches) located in China, India, Zambia, and the United States | en.cn-cg.com |
| Headcount | 2,088 employees as of March 2026 | info.creditriskmonitor.com |
| Revenue | 6.56 billion CNY for the fiscal year 2025 | static.cninfo.com.cn · news.futunn.com · sa.marketscreener.com |
Independent sources: en.cn-cg.com · info.creditriskmonitor.com · news.futunn.com · sa.marketscreener.com · static.cninfo.com.cn · wlw.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Green extraction (SC-CO2, DES, ultrasound) | downstream-purification | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.